Yahoo-konsernin evästeet ja tietosuojan hallinnat

Yahoo-konsernissa on useita sivustoja ja sovelluksia, joista omistamme ja operoimme. Nämä sisältävät Yahoo, AOL, Engadget, Rivals, In The Know sekä Makers. Jos haluat muokata evästeiden käyttöä tai tiedotusvelvoitusten hallintoa, voit napsauttaa “Hallitse tietosuoja-asetuksia” -linkki sivuiltamme ja sovelluksiltamme. Source: https://consent.yahoo.com/v2/collectConsent?sessionId=3_cc-session_18f8798e-9cb9-4843-9aaa-48933ac9bc05

James Beard Gala Highlights Diverse Voices Amid Immigration Debate

The 35th annual James Beard Restaurant and Chef Gala took place at the Lyric Opera in Chicago, showcasing a diverse range of chefs, restaurateurs, and industry leaders. The event focused on the political moment, with many nominees speaking out against ICE raids and immigration policies. James Beard Foundation CEO Clare Reichenbach highlighted the industry’s reliance … Read more

Is it Time to Ride the Tesla ETF Wave?

Tesla Inc.’s (TSLA) shares have recently experienced a significant rebound, gaining 13.9% in the past week after a dismal start to the month due to a feud between CEO Elon Musk and former US President Donald Trump. This recent turnaround is largely attributed to Musk’s attempt to mend ties with the U.S. government. However, despite … Read more

Browns’ Trade Down a Bold Move for GM Berry

The 2025 NFL offseason is wrapping up, and while some teams still have moves to make before training camp, the Cleveland Browns’ decision to trade down from the second overall pick has been hailed as one of the offseason’s best. General Manager Andrew Berry made the move in exchange for a package that includes defensive … Read more

Harvard Researchers Secure $39M in Turkish Funding Amid Trump Administration Cuts

Harvard University is reeling from extensive cuts to federal funding by the Trump administration, but researcher Gökhan Hotamışlıgil has secured his lab’s future with a significant investment from a Turkish investment group. Hotamșličılıgil has secured approximately $39 million in funding over 10 years to support his research on new antibodies for obesity and metabolic diseases. … Read more

Chase Sapphire Reserve Relaunches with Expanded Perks and Steeper Fee

The Chase Sapphire Reserve is getting a significant upgrade, launching June 23 with over $2,700 in value for cardholders. The refreshed card promises to deliver elevated benefits and greater value in areas that its current members are most passionate about. The new version comes at an annual fee of $795, up from $550—a 44.5 percent … Read more

Breakthrough HIV Prevention Drug Set to be Released at $25 a Year

A new study has revealed that the highly anticipated drug Lenacapavir, set to launch in the US this week, could potentially be sold for just $25 a year. The twice-yearly injection is capable of preventing someone from being infected with HIV and has shown promising results in clinical trials. The medication is expected to receive … Read more

Gilead’s PrEP Injection Set for FDA Approval Decision

Gilead’s lenacapavir injection, part of its approved HIV treatment form Sunlenca, is up for approval as a preventive medication (PrEP) on June 19. The therapy claims to almost entirely prevent HIV transmission. However, the decision comes amid controversy surrounding recent federal politics and their impact on healthcare policies. Source: https://endpoints.news/with-hiv-prevention-under-attack-how-might-gileads-new-prep-injection-fare

Israel Confronts Unprecedented Missile Barrages from Iran

Israelis are facing a shattered sense of security as the country is hit by deadly missile barrages from Iran for the fourth night in a row. The attacks, which have also targeted residential areas, have killed over 224 people and wounded at least 1,481, according to Iranian authorities. The Israeli military’s Home Front Command has … Read more